Related Experiment Video
Updated: Nov 5, 2025

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
No more hypoglycaemia on days with physical activity and unrestricted diet when using a closed-loop system for
Sylvia Franc1,2,3, Pierre-Yves Benhamou4, Sophie Borot5
1Department of Diabetes, Sud-Francilien Hospital, Corbeil-Essonnes, France.
Insights
The Diabeloop Generation-1 (DBLG1) system effectively prevents hypoglycemia during physical activity (PA) in type 1 diabetes patients. It achieves this by adjusting insulin and recommending carbohydrates, maintaining glucose control despite exercise.
Area of Science:
- Endocrinology
- Diabetes Technology
Background:
- Physical activity (PA) poses a risk of hypoglycemia for type 1 diabetes (T1D) patients.
- Closed-loop systems aim to mitigate exercise-induced glycemic variability.
Purpose of the Study:
- To evaluate the efficacy of the Diabeloop Generation-1 (DBLG1) closed-loop system in preventing PA-induced hypoglycemia.
- To analyze glycemic outcomes during PA in real-life conditions.
Main Methods:
- Post hoc analysis of the Diabeloop WP7 randomized controlled trial.
- Comparison of glycemic outcomes between days with and without PA in 56 T1D patients using DBLG1 for 12 weeks.
- Monitoring of time in hypoglycemia, insulin delivery, and carbohydrate intake.
Main Results:
- No significant difference in time spent below 70 mg/dL between days with and without PA (2.0% vs. 2.2%).
- Significantly higher recommended carbohydrate intake (41.1g vs. 21.8g) and lower insulin delivery (31.5U vs. 34.0U) on PA days.
- Increased time in hyperglycemia and glycemic variation coefficient observed on PA days.
Conclusions:
- The DBLG1 system effectively prevents hypoglycemia during physical activity in T1D patients under real-world conditions.
- Insulin reduction and carbohydrate recommendations are key mechanisms for this benefit.
- While hypoglycemia is avoided, hyperglycemia and glycemic variability may increase during PA.
Abstract:
A post hoc analysis of the Diabeloop WP7 multicentre, randomized controlled trial was performed to investigate the efficacy of the Diabeloop Generation-1 (DBLG1) closed-loop system in controlling the hypoglycaemia induced by physical activity (PA) in real-life conditions. Glycaemic outcomes were compared between days with and without PA in 56 patients with type 1 diabetes (T1D) using DBLG1 for 12 weeks. After the patient announces a PA, DBLG1 reduces insulin delivery and, if necessary, calculates the amount of preventive carbohydrates (CHO). Daily time spent in the interstitial glucose range less than 70 mg/dL was not significantly different between days with and without PA (2.0% ± 1.5% vs. 2.2% ± 1.1%), regardless of the intensity or duration of the PA. Preventive CHO intake recommended by the system was significantly higher in days with PA (41.1 ± 35.5 vs. 21.8 ± 28.5 g/day; P < .0001), and insulin delivery was significantly lower (31.5 ± 10.5 vs. 34.0 ± 10.5 U/day; P < .0001). The time spent in hyperglycaemia and the glycaemic variation coefficient increased significantly on days with PA. In real-life conditions, the use of DBLG1 avoids PA-induced hypoglycaemia. Insulin adjustments and preventive CHO recommendation may explain this therapeutic benefit.
More Related Videos
07:22Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
06:13Author Spotlight: Exploring the Impact of Reduced Resistance Exercise Volume on Metabolic Health
Published on: December 1, 2023
Related Concept Videos
Feedback Loops
Hypoglycemia and Glucagon
What is Homeostasis?
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Hormones Regulating Blood Glucose
In addition to accelerating glucose uptake and utilization, insulin has...
Diabetes Mellitus: Type 2 and Gestational